These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15146442

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Clinical consequences of antiphospholipid antibodies.
    Derksen RH, de Groot PG.
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [Abstract] [Full Text] [Related]

  • 43. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE.
    Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE, Gonzalez-Pares EN, Rivera C.
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [Abstract] [Full Text] [Related]

  • 47. Clinical implication of antiphospholipid antibodies in systemic lupus erythematosus.
    Stratta P, Canavese C, Thea A, Tognarelli G, Dogliani M, Porcu MC, Garis G, Borchiellini A, Schinco PC, Vercellone A.
    Contrib Nephrol; 1992 Dec; 99():123-5. PubMed ID: 1458917
    [No Abstract] [Full Text] [Related]

  • 48. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y.
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [Abstract] [Full Text] [Related]

  • 49. Prolonged bleeding time in patients with lupus anticoagulant.
    Orlando E, Cortelazzo S, Marchetti M, Sanfratello R, Barbui T.
    Thromb Haemost; 1992 Nov 10; 68(5):495-9. PubMed ID: 1455393
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The course of anticardiolipin antibody levels under immunoadsorption therapy.
    Hauser AC, Hauser L, Pabinger-Fasching I, Quehenberger P, Derfler K, Hörl WH.
    Am J Kidney Dis; 2005 Sep 10; 46(3):446-54. PubMed ID: 16129206
    [Abstract] [Full Text] [Related]

  • 52. Cutaneous manifestations associated with antiphospholipid antibodies.
    Diógenes MJ, Diógenes PC, de Morais Carneiro RM, Neto CC, Duarte FB, Holanda RR.
    Int J Dermatol; 2004 Sep 10; 43(9):632-7. PubMed ID: 15357740
    [Abstract] [Full Text] [Related]

  • 53. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI, Manea EM.
    Roum Arch Microbiol Immunol; 2006 Sep 10; 65(1-2):66-74. PubMed ID: 17877113
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Surgical experience on patients with serum lupus anticoagulants. A report of two cases.
    Minezaki T, Ichikawa Y.
    Tokai J Exp Clin Med; 1993 Dec 10; 18(3-6):95-7. PubMed ID: 7701535
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun 10; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 59. Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients.
    Chen WH, Lin HS, Kao YF, Lan MY, Liu JS.
    Clin Appl Thromb Hemost; 2007 Oct 10; 13(4):398-403. PubMed ID: 17911191
    [Abstract] [Full Text] [Related]

  • 60. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies].
    Elezović I, Matijević-Aleksić N, Rolović Z.
    Srp Arh Celok Lek; 1994 Oct 10; 122(5-6):179-81. PubMed ID: 17977423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.